ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Angiotensin II Receptor Blocker (ARBs) API Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-16X4834
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Angiotensin II Receptor Blocker ARBs API Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Angiotensin II Receptor Blocker (ARBs) API Market Research Report 2025

Code: QYRE-Auto-16X4834
Report
June 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceutical
Aurobindo Pharma
Viatris
Tianyu Pharma
Huahai Pharmaceutical
Menovo
Rundu Pharma
Kinglyuan Pharmaceutical
Second Pharma
Apeloa
Jiangxi Synergy Pharmaceutical

Angiotensin II Receptor Blocker (ARBs) API Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Angiotensin II Receptor Blocker (ARBs) API Market

Angiotensin II Receptor Blocker (ARBs) API Market

The global market for Angiotensin II Receptor Blocker (ARBs) API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Valsartan, losartan, irbesartan and other “-sartan” drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Angiotensin II Receptor Blocker (ARBs) API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin II Receptor Blocker (ARBs) API.
The Angiotensin II Receptor Blocker (ARBs) API market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Angiotensin II Receptor Blocker (ARBs) API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiotensin II Receptor Blocker (ARBs) API companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Angiotensin II Receptor Blocker (ARBs) API Market Report

Report Metric Details
Report Name Angiotensin II Receptor Blocker (ARBs) API Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva Pharmaceutical, Aurobindo Pharma, Viatris, Tianyu Pharma, Huahai Pharmaceutical, Menovo, Rundu Pharma, Kinglyuan Pharmaceutical, Second Pharma, Apeloa, Jiangxi Synergy Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Angiotensin II Receptor Blocker (ARBs) API company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Angiotensin II Receptor Blocker (ARBs) API Market report?

Ans: The main players in the Angiotensin II Receptor Blocker (ARBs) API Market are Teva Pharmaceutical, Aurobindo Pharma, Viatris, Tianyu Pharma, Huahai Pharmaceutical, Menovo, Rundu Pharma, Kinglyuan Pharmaceutical, Second Pharma, Apeloa, Jiangxi Synergy Pharmaceutical

What are the Application segmentation covered in the Angiotensin II Receptor Blocker (ARBs) API Market report?

Ans: The Applications covered in the Angiotensin II Receptor Blocker (ARBs) API Market report are Essential Hypertension, Secondary Hypertension

What are the Type segmentation covered in the Angiotensin II Receptor Blocker (ARBs) API Market report?

Ans: The Types covered in the Angiotensin II Receptor Blocker (ARBs) API Market report are Valsartan, Irbesartan, Telmisartan, Losartan, Candesartan, Olmesartan, Others

Recommended Reports

Hypertension Treatment

Sartan APIs

ACE Inhibitors

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Valsartan
1.2.3 Irbesartan
1.2.4 Telmisartan
1.2.5 Losartan
1.2.6 Candesartan
1.2.7 Olmesartan
1.2.8 Others
1.3 Market by Application
1.3.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Essential Hypertension
1.3.3 Secondary Hypertension
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Perspective (2020-2031)
2.2 Global Angiotensin II Receptor Blocker (ARBs) API Growth Trends by Region
2.2.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Region (2020-2025)
2.2.3 Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2026-2031)
2.3 Angiotensin II Receptor Blocker (ARBs) API Market Dynamics
2.3.1 Angiotensin II Receptor Blocker (ARBs) API Industry Trends
2.3.2 Angiotensin II Receptor Blocker (ARBs) API Market Drivers
2.3.3 Angiotensin II Receptor Blocker (ARBs) API Market Challenges
2.3.4 Angiotensin II Receptor Blocker (ARBs) API Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue
3.1.1 Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Revenue (2020-2025)
3.1.2 Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Players (2020-2025)
3.2 Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Angiotensin II Receptor Blocker (ARBs) API Revenue
3.4 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio
3.4.1 Global Angiotensin II Receptor Blocker (ARBs) API Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2024
3.5 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API Head office and Area Served
3.6 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Product and Application
3.7 Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Type
4.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Type (2020-2025)
4.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2026-2031)
5 Angiotensin II Receptor Blocker (ARBs) API Breakdown Data by Application
5.1 Global Angiotensin II Receptor Blocker (ARBs) API Historic Market Size by Application (2020-2025)
5.2 Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
6.2 North America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
6.4 North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
7.2 Europe Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
7.4 Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
8.2 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025)
8.4 Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
9.2 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
9.4 Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size (2020-2031)
10.2 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025)
10.4 Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical
11.1.1 Teva Pharmaceutical Company Details
11.1.2 Teva Pharmaceutical Business Overview
11.1.3 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.1.4 Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.1.5 Teva Pharmaceutical Recent Development
11.2 Aurobindo Pharma
11.2.1 Aurobindo Pharma Company Details
11.2.2 Aurobindo Pharma Business Overview
11.2.3 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.2.4 Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.2.5 Aurobindo Pharma Recent Development
11.3 Viatris
11.3.1 Viatris Company Details
11.3.2 Viatris Business Overview
11.3.3 Viatris Angiotensin II Receptor Blocker (ARBs) API Introduction
11.3.4 Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.3.5 Viatris Recent Development
11.4 Tianyu Pharma
11.4.1 Tianyu Pharma Company Details
11.4.2 Tianyu Pharma Business Overview
11.4.3 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.4.4 Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.4.5 Tianyu Pharma Recent Development
11.5 Huahai Pharmaceutical
11.5.1 Huahai Pharmaceutical Company Details
11.5.2 Huahai Pharmaceutical Business Overview
11.5.3 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.5.4 Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.5.5 Huahai Pharmaceutical Recent Development
11.6 Menovo
11.6.1 Menovo Company Details
11.6.2 Menovo Business Overview
11.6.3 Menovo Angiotensin II Receptor Blocker (ARBs) API Introduction
11.6.4 Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.6.5 Menovo Recent Development
11.7 Rundu Pharma
11.7.1 Rundu Pharma Company Details
11.7.2 Rundu Pharma Business Overview
11.7.3 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.7.4 Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.7.5 Rundu Pharma Recent Development
11.8 Kinglyuan Pharmaceutical
11.8.1 Kinglyuan Pharmaceutical Company Details
11.8.2 Kinglyuan Pharmaceutical Business Overview
11.8.3 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.8.4 Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.8.5 Kinglyuan Pharmaceutical Recent Development
11.9 Second Pharma
11.9.1 Second Pharma Company Details
11.9.2 Second Pharma Business Overview
11.9.3 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Introduction
11.9.4 Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.9.5 Second Pharma Recent Development
11.10 Apeloa
11.10.1 Apeloa Company Details
11.10.2 Apeloa Business Overview
11.10.3 Apeloa Angiotensin II Receptor Blocker (ARBs) API Introduction
11.10.4 Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.10.5 Apeloa Recent Development
11.11 Jiangxi Synergy Pharmaceutical
11.11.1 Jiangxi Synergy Pharmaceutical Company Details
11.11.2 Jiangxi Synergy Pharmaceutical Business Overview
11.11.3 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Introduction
11.11.4 Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
11.11.5 Jiangxi Synergy Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Teva Pharmaceutical
Aurobindo Pharma
Viatris
Tianyu Pharma
Huahai Pharmaceutical
Menovo
Rundu Pharma
Kinglyuan Pharmaceutical
Second Pharma
Apeloa
Jiangxi Synergy Pharmaceutical
List of Tables
 Table 1. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Valsartan
 Table 3. Key Players of Irbesartan
 Table 4. Key Players of Telmisartan
 Table 5. Key Players of Losartan
 Table 6. Key Players of Candesartan
 Table 7. Key Players of Olmesartan
 Table 8. Key Players of Others
 Table 9. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2020-2025)
 Table 13. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2026-2031)
 Table 15. Angiotensin II Receptor Blocker (ARBs) API Market Trends
 Table 16. Angiotensin II Receptor Blocker (ARBs) API Market Drivers
 Table 17. Angiotensin II Receptor Blocker (ARBs) API Market Challenges
 Table 18. Angiotensin II Receptor Blocker (ARBs) API Market Restraints
 Table 19. Global Angiotensin II Receptor Blocker (ARBs) API Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players (2020-2025)
 Table 21. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2024)
 Table 22. Ranking of Global Top Angiotensin II Receptor Blocker (ARBs) API Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Headquarters and Area Served
 Table 25. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Product and Application
 Table 26. Global Key Players of Angiotensin II Receptor Blocker (ARBs) API, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2020-2025)
 Table 30. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Type (2026-2031)
 Table 32. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2020-2025)
 Table 34. Global Angiotensin II Receptor Blocker (ARBs) API Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Angiotensin II Receptor Blocker (ARBs) API Revenue Market Share by Application (2026-2031)
 Table 36. North America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Teva Pharmaceutical Company Details
 Table 52. Teva Pharmaceutical Business Overview
 Table 53. Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
 Table 54. Teva Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 55. Teva Pharmaceutical Recent Development
 Table 56. Aurobindo Pharma Company Details
 Table 57. Aurobindo Pharma Business Overview
 Table 58. Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product
 Table 59. Aurobindo Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 60. Aurobindo Pharma Recent Development
 Table 61. Viatris Company Details
 Table 62. Viatris Business Overview
 Table 63. Viatris Angiotensin II Receptor Blocker (ARBs) API Product
 Table 64. Viatris Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 65. Viatris Recent Development
 Table 66. Tianyu Pharma Company Details
 Table 67. Tianyu Pharma Business Overview
 Table 68. Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product
 Table 69. Tianyu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 70. Tianyu Pharma Recent Development
 Table 71. Huahai Pharmaceutical Company Details
 Table 72. Huahai Pharmaceutical Business Overview
 Table 73. Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
 Table 74. Huahai Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 75. Huahai Pharmaceutical Recent Development
 Table 76. Menovo Company Details
 Table 77. Menovo Business Overview
 Table 78. Menovo Angiotensin II Receptor Blocker (ARBs) API Product
 Table 79. Menovo Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 80. Menovo Recent Development
 Table 81. Rundu Pharma Company Details
 Table 82. Rundu Pharma Business Overview
 Table 83. Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product
 Table 84. Rundu Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 85. Rundu Pharma Recent Development
 Table 86. Kinglyuan Pharmaceutical Company Details
 Table 87. Kinglyuan Pharmaceutical Business Overview
 Table 88. Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
 Table 89. Kinglyuan Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 90. Kinglyuan Pharmaceutical Recent Development
 Table 91. Second Pharma Company Details
 Table 92. Second Pharma Business Overview
 Table 93. Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product
 Table 94. Second Pharma Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 95. Second Pharma Recent Development
 Table 96. Apeloa Company Details
 Table 97. Apeloa Business Overview
 Table 98. Apeloa Angiotensin II Receptor Blocker (ARBs) API Product
 Table 99. Apeloa Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 100. Apeloa Recent Development
 Table 101. Jiangxi Synergy Pharmaceutical Company Details
 Table 102. Jiangxi Synergy Pharmaceutical Business Overview
 Table 103. Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product
 Table 104. Jiangxi Synergy Pharmaceutical Revenue in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025) & (US$ Million)
 Table 105. Jiangxi Synergy Pharmaceutical Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Angiotensin II Receptor Blocker (ARBs) API Picture
 Figure 2. Global Angiotensin II Receptor Blocker (ARBs) API Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Type: 2024 VS 2031
 Figure 4. Valsartan Features
 Figure 5. Irbesartan Features
 Figure 6. Telmisartan Features
 Figure 7. Losartan Features
 Figure 8. Candesartan Features
 Figure 9. Olmesartan Features
 Figure 10. Others Features
 Figure 11. Global Angiotensin II Receptor Blocker (ARBs) API Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Application: 2024 VS 2031
 Figure 13. Essential Hypertension Case Studies
 Figure 14. Secondary Hypertension Case Studies
 Figure 15. Angiotensin II Receptor Blocker (ARBs) API Report Years Considered
 Figure 16. Global Angiotensin II Receptor Blocker (ARBs) API Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Angiotensin II Receptor Blocker (ARBs) API Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Region: 2024 VS 2031
 Figure 19. Global Angiotensin II Receptor Blocker (ARBs) API Market Share by Players in 2024
 Figure 20. Global Top Angiotensin II Receptor Blocker (ARBs) API Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blocker (ARBs) API as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Angiotensin II Receptor Blocker (ARBs) API Revenue in 2024
 Figure 22. North America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
 Figure 24. United States Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
 Figure 28. Germany Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Angiotensin II Receptor Blocker (ARBs) API Market Share by Region (2020-2031)
 Figure 36. China Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
 Figure 44. Mexico Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Angiotensin II Receptor Blocker (ARBs) API Market Share by Country (2020-2031)
 Figure 48. Turkey Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Angiotensin II Receptor Blocker (ARBs) API Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Teva Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 52. Aurobindo Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 53. Viatris Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 54. Tianyu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 55. Huahai Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 56. Menovo Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 57. Rundu Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 58. Kinglyuan Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 59. Second Pharma Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 60. Apeloa Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 61. Jiangxi Synergy Pharmaceutical Revenue Growth Rate in Angiotensin II Receptor Blocker (ARBs) API Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Angiotensin II Receptor Blockers Market Insights Forecast to 2030
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irbesartan Market Research Report 2024
Global Sartan series Drugs Market Research Report 2024
Global Angiotensin II Receptor Market Research Report 2024
Global Irbesartan Tablets Market Insights Forecast to 2030
Valsartan Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Valsartan API Market Research Report 2025
Renin Angiotensin System RAS Acting Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Peptide Drugs of Angiotensin II Receptor Antagonist Market Research Report 2024
Angiotensin Converting Enzyme Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angiotensin Converting Enzyme ACE Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renin Angiotensin System RAS Inhibitor Market Research Report 2024
Global Sacubitril API Market Research Report 2025
Global Losartan Potassium API Market Research Report 2024
Global Ramipril API Market Research Report 2025
Global Valsartan Capsules Market Research Report 2024
Global Irbesartan API Market Research Report 2024
Global Enalapril API Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions